{"@context":"http://schema.org","@type":"Dataset","@id":"https://doi.org/10.13130/RD_UNIMI/JEKKDR","identifier":"https://doi.org/10.13130/RD_UNIMI/JEKKDR","name":"Replication Data for DCHQ5 for \"A Comparison of Doxorubicin-Resistant Colon Cancer LoVo and Leukemia HL60 Cells: Common Features, Different Underlying Mechanisms\"","creator":[{"@type":"Person","givenName":"Sara","familyName":"Castiglioni","affiliation":{"@type":"Organization","name":"University of Milan"},"name":"Castiglioni, Sara"}],"author":[{"@type":"Person","givenName":"Sara","familyName":"Castiglioni","affiliation":{"@type":"Organization","name":"University of Milan"},"name":"Castiglioni, Sara"}],"datePublished":"2021-09-22","dateModified":"2023-12-05","version":"1","description":"Replication Data for: DCHQ5","keywords":["Medicine, Health and Life Sciences"],"citation":[{"@type":"CreativeWork","name":"Locatelli L, Cazzaniga A, Fedele G, Zocchi M, Scrimieri R, Moscheni C, Castiglioni S, Maier JA. A Comparison of Doxorubicin-Resistant Colon Cancer LoVo and Leukemia HL60 Cells: Common Features, Different Underlying Mechanisms. Curr Issues Mol Biol. 2021 May 22;43(1):163-175. doi: 10.3390/cimb43010014. PMID: 34067290; PMCID: PMC8929017."}],"license":"http://creativecommons.org/publicdomain/zero/1.0","includedInDataCatalog":{"@type":"DataCatalog","name":"UNIMI Dataverse","url":"https://dataverse.unimi.it"},"publisher":{"@type":"Organization","name":"UNIMI Dataverse"},"provider":{"@type":"Organization","name":"UNIMI Dataverse"},"distribution":[{"@type":"DataDownload","name":"DCHQ5.xlsx","encodingFormat":"application/vnd.openxmlformats-officedocument.spreadsheetml.sheet","contentSize":63990,"@id":"https://doi.org/10.13130/RD_UNIMI/JEKKDR/ZJF1BM","identifier":"https://doi.org/10.13130/RD_UNIMI/JEKKDR/ZJF1BM","contentUrl":"https://dataverse.unimi.it/api/access/datafile/6578"}]}